Risk Of Sterilization Plant Shutdowns Across US Sends Shockwave Through Industry
Executive Summary
While a number of US states are taking actions that could potentially ban or limit ethylene oxide (EtO) sterilization plants in their communities, the FDA, industry and others are raising the alarm that such moves could lead to a shortage of medical devices critical to patients.
You may also be interested in...
US FDA Looks To Balance Device Sterilization With Environmental Concerns
While half of all medical devices in the US are sterilized with ethylene oxide, emissions from the gas pose potential environmental hazards that are attracting federal action.
FDA Mulls Master File Pilot For Makers Of PMA-Approved Devices Sterilized Using Radiation
The US FDA may launch a pilot program that would allow PMA-holders to submit updated master files to the agency if the manufacturers change sterilization methods.
FDA Launches Pilot For Makers Of Single-Use 510(k) Devices To Encourage Sterilization Switch
Under the US FDA’s voluntary 510(k) Sterility Change Master File Pilot Program, nine firms will be selected to send to the agency updated master files that detail novel sterilization processes without the need to submit a new 510(k). The goal is to move industry away from using ethylene oxide (EtO) to sterilize devices.